Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 80 out of 100. How common it is

Reviewed as evidence on: Menopause timing / hormone therapy (estrogen-only) and dementia risk and AD neuropathology 7 studies (what the news said). Being listed means the study bears on the question, not that it agrees with the news.

Topic: Risk, prevention and care in population studies

Plain-language summary

Context The Women's Health Initiative Memory Study (WHIMS) previously found increased risk for dementia and no effect on mild cognitive impairment (MCI) in women treated with conjugated equine estrogens (CEE) plus medroxyprogesterone acetate (MPA). Results In the estrogen-alone trial, 47 participants were diagnosed with probable dementia, of whom 28 were assigned to CEE and 19 to placebo (hazard ratio [HR], 1.49; 95% confidence interval [CI], 0.83-2.66). When data were pooled per the original WHIMS protocol, the overall HR for probable dementia was 1.76 (95% CI, 1.19-2.60; P =.005).

What this study adds

Evidence grade: High

This is a trial of 4,532 participants. In the estrogen-alone arm of the Women's Health Initiative Memory Study, 28 women assigned to conjugated equine estrogens and 19 assigned to placebo were diagnosed with probable dementia (hazard ratio 1.49; 95% CI 0.83–2.66). That range includes no difference, so this trial on its own did not show a statistically significant effect.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Shumaker, S. A., Legault, C., Kuller, L., Rapp, SR., Thal, L., Lane, D. S., et al. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. https://doi.org/10.1001/jama.291.24.2947

Vancouver

Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004. doi:10.1001/jama.291.24.2947. PMID: 15213206.

BibTeX

@article{shumaker2004-15213206,
  author  = {Shumaker, S. A. and Legault, C. and Kuller, L. and Rapp, SR. and Thal, L. and Lane, D. S. and Fillit, H. and Stefanick, M. L. and others},
  title   = {{Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study}},
  journal = {JAMA},
  year    = {2004},
  doi     = {10.1001/jama.291.24.2947},
  pmid    = {15213206},
  url     = {https://doi.org/10.1001/jama.291.24.2947}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

In the estrogen-alone arm of the Women's Health Initiative Memory Study, 28 women assigned to conjugated equine estrogens and 19 assigned to placebo were diagnosed with probable dementia (hazard ratio 1.49; 95% CI 0.83–2.66). That range includes no difference, so this trial on its own did not show a statistically significant effect. When the data were pooled "per the original WHIMS protocol", the overall hazard ratio was 1.76 (95% CI 1.19–2.60; P = .005). Neither result suggests this hormone protected against dementia.

Study details

How this study scored 80/100
How this study's score is builtJournal tier 10 of 10; Journal's citation record 4 of 4; Study design 11 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 3 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 1 of 2; Times cited 7 of 7; Citations per year 5 of 5; Impact for its field and year 6 of 6; Cited by studies here 4 of 6; Still being cited 3 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 80 of 100.80 of 100 points earned20 not earned

Published in a top-tier journal, and it is a randomized controlled trial. Scored zero for effect reported because the record does not state it.

ComponentPointsWhy
Journal tier 10 / 10 Tier 1 — top-tier general journal (JAMA)
Journal's citation record 4 / 4 JAMA: journal h-index 1,011 (OpenAlex, 2026-10-29)
Study design 11 / 12 A randomized controlled trial (from PubMed type “Randomized Controlled Trial”)
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2004 — older than 20 years, still counted
Sample size 3 / 4 4,532 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 1 / 2 Randomized (as stated in the record)
Times cited 7 / 7 Cited 1,368 times (OpenAlex, 2026-10-10)
Citations per year 5 / 5 57.0 citations a year over 24 year(s) since 2004
Impact for its field and year 6 / 6 Cited 68.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 4 / 6 Cited by 39 other studies in this library
Still being cited 3 / 4 Cited 120 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Sally Ann Shumaker: h-index 66 (OpenAlex, whole career)
Institution's track record 1 / 3 Wake Forest University: institution h-index 835 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 15213206)
Free to read 0 / 2 Behind a paywall — scores zero
Total 80 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.

Later studies that cite this one

39 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in How common it is from nearby years

Studies sharing this one's topic tags

Similar studies

More on How common it is

See all studies in How common it is →